Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3054 (LINC03054) is a human long non-coding RNA (lncRNA) gene located on chromosome 8, also referenced as AC022915.1[1][3][5][7][9]. LINC03054 is classified as a non-coding RNA and does not encode a protein product[1][3][5][7][9]. There are currently no literature reports identifying it as a therapeutic target, nor are there established biological functions, disease roles, associated drugs, mechanisms of action, biomarker status, or safety concerns related to this lncRNA in available curated databases or large-scale genomic resources[1][3][5][7][9]. Therapeutic target: There is no evidence that LINC03054 functions as a therapeutic target such as a receptor, enzyme, transporter, transcription factor, or any classical drug target category[1][3][5][7][9]. Molecular classification: The RNA is classified as a long non-coding RNA (lncRNA), fitting into the "Other" category, specifically non-coding RNA family[1][3][5][7][9]. Aliases: The most widely used alternative name is AC022915.1[7]. Function and disease role: No published functional or pathological roles have been assigned in current knowledgebases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3054 (LINC03054).